there’s a big difference between the standard at-home antigen test and a PCR (molecular) test. Almost five years in, it’s ...

founder and CEO of the molecular diagnostics company Seegene, which is based in Seoul, South Korea. Polymerase chain reaction (PCR) tests, which amplify tiny snippets of nucleic acids in a ...

As the incidence of genetic disorders increases, there is a corresponding rise in the demand for molecular biology enzymes, kits, and reagents essential for conducting tests. These tools are vital for ...

Growing a molecular diagnostics company in South Korea ... Under these circumstances, the current PCR testing isn’t viable for smaller clinics and hospitals. Chun and his colleagues at Seegene ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...

New PCR-based approaches simplify molecular testing for health issues in infants, making diagnostic approaches simpler and more accessible across laboratories. The Eonis™ Q system from Revvity is an ...

The advent of innovative PCR-based techniques that streamline and enhance existing approaches, such as dry PCR, promises to further improve newborn screening laboratory workflows. Download this ...

The deal will let ABL commercialize tests equivalent to those that had been offered by the shuttered Siemens subsidiary Fast Track Diagnostics.

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.